POLLICINO, Teresa
 Distribuzione geografica
Continente #
NA - Nord America 2.735
EU - Europa 2.617
AS - Asia 771
SA - Sud America 17
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.152
Nazione #
US - Stati Uniti d'America 2.724
IE - Irlanda 777
SE - Svezia 684
CN - Cina 438
IT - Italia 345
SG - Singapore 258
DE - Germania 190
UA - Ucraina 170
PL - Polonia 153
FI - Finlandia 132
GB - Regno Unito 56
IN - India 34
FR - Francia 33
BE - Belgio 30
VN - Vietnam 17
CZ - Repubblica Ceca 16
BR - Brasile 15
ID - Indonesia 14
CA - Canada 11
RU - Federazione Russa 10
NZ - Nuova Zelanda 8
NL - Olanda 6
ES - Italia 5
BD - Bangladesh 4
IR - Iran 3
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
EU - Europa 2
AZ - Azerbaigian 1
BG - Bulgaria 1
HR - Croazia 1
HU - Ungheria 1
LV - Lettonia 1
MY - Malesia 1
PT - Portogallo 1
RO - Romania 1
TR - Turchia 1
Totale 6.152
Città #
Dublin 777
Chandler 543
Nyköping 408
Jacksonville 371
Ashburn 327
Beijing 218
Messina 205
Singapore 199
Warsaw 147
Princeton 119
Ann Arbor 117
Medford 98
Cambridge 90
Des Moines 82
Boardman 63
Munich 57
Dearborn 51
Helsinki 41
Jinan 40
Houston 37
Wilmington 36
Woodbridge 36
Brussels 30
Pune 27
San Mateo 27
Los Angeles 23
Falls Church 21
Nanjing 21
New York 17
Dong Ket 16
Zhengzhou 16
Shenyang 15
Jakarta 14
Rome 14
Rosolini 14
Brno 13
Hebei 13
Brasília 11
Norwalk 11
Tianjin 11
Guangzhou 9
Haikou 9
Ottawa 8
Seattle 8
Tappahannock 8
Fuzhou 6
Hangzhou 6
Nanchang 6
Ningbo 6
Taizhou 6
Whakatane 6
Catania 5
Changsha 5
Lanzhou 5
Washington 5
Auburn Hills 4
Avola 4
Bremen 4
Lappeenranta 4
Qingdao 4
Radomsko 4
Taiyuan 4
Ardabil 3
Hyderabad 3
Madrid 3
New Haven 3
Olomouc 3
Pachino 3
Reggio Calabria 3
Saint Petersburg 3
San Giovanni la Punta 3
Amsterdam 2
Belpasso 2
Bogra 2
Catanzaro 2
Chicago 2
Culver City 2
Edinburgh 2
Jiaxing 2
Kraków 2
Leawood 2
Manchester 2
Manerba del Garda 2
Monmouth Junction 2
Nuremberg 2
Piazza Armerina 2
Verona 2
Vienna 2
Villejuif 2
Vittoria 2
Wellington 2
Zurich 2
Afyonkarahisar 1
Augusta 1
Baku 1
Baotou 1
Barcelona 1
Bari 1
Berlin 1
Boston 1
Totale 4.579
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 269
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 133
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 127
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 106
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 102
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 101
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 96
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 88
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 88
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 84
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 83
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 82
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 81
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 76
Obesity and liver cancer 76
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 72
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 67
FULMINANT-HEPATITIS ASSOCIATED WITH THE INTRAFAMILIAR SPREAD OF A PRE-S2 DEFECTIVE HBV VARIANT AND THE LATE EMERGENCE OF HBEAG- MINUS VIRAL STRAINS 66
Control of cccDNA function in hepatitis B virus infection. 66
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 63
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 63
A 2010 update on occult hepatitis B infection. 63
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 63
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 62
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 62
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice 62
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 62
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 61
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 61
Targeting Hepatitis B virus infected cells with a T-cell receptor like antibody 61
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 61
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 61
Clinical virology of hepatitis B virus infection 60
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 60
Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. 60
[A glance into the past ... Southern and northern blot: really superseded?] 60
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 60
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 60
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 59
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 59
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 58
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 58
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 58
Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. 57
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 57
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 57
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 57
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo 57
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 57
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 56
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 56
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 55
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 55
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 53
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 53
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 52
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 52
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 51
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 51
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 51
Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. 50
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 48
Pro-apoptotic effect of the hepatitis B virus X gene. 48
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 48
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 47
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 47
The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. 47
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 47
Disease progression and liver cancer in the ferroportin disease. 47
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 47
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 PRODUCTION WHICH IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY IN HEPATOMA CELL LINES 46
Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways. 46
High prevalence of preS2-defective hepatitis B virus (HBV) infection in patients with type b fulminant hepatitis. 46
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 45
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 45
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3 infected patients within the Italian network VIRONET-C 44
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 44
Occult hepatitis B virus and hepatocellular carcinoma. 43
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 43
Heterogeneity of HBV genome. 42
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 41
Occult HBV infection 41
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 41
What is the clinical impact of occult hepatitis B virus infection? 40
Occult hepatitis B virus infection 39
Type II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation. 39
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop 39
Occult hepatitis B virus infection 38
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. 38
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 38
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 38
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 37
Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma. 36
Hepatitis B viral replication influences the expression of natural killer cell ligands 36
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 36
PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection. 35
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 35
HBV-integration studies in the clinic: Role in the natural history of infection 34
Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status 33
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 32
Totale 5.913
Categoria #
all - tutte 26.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020629 0 0 0 0 7 57 93 84 27 156 174 31
2020/2021833 77 18 154 50 68 83 39 96 44 103 51 50
2021/2022745 7 57 27 30 57 16 63 33 18 99 99 239
2022/20232.196 164 250 104 176 138 224 45 100 906 14 61 14
2023/2024719 50 111 26 61 41 103 2 228 3 23 20 51
2024/2025485 47 19 80 227 112 0 0 0 0 0 0 0
Totale 6.341